Literature DB >> 8106386

The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.

L Mery1, F Boulay.   

Abstract

The N-formylated tripeptide, formylmethionylleucyl-phenylalanine (fMLP), and the 74-amino-acid long human C5a anaphylatoxin activate phagocytic cells via two structurally related G protein-coupled receptors (FPR and C5aR), which are 34% identical in amino acid sequence. C5aR chimeras were constructed in which the entire NH2-terminal extracellular sequence or part of it was replaced by the counterparts from FPR or FPRH. Although the NH2-terminal region of C5aR presents an extremely high interspecies variability, substitution of the entire NH2-terminal sequence of C5aR by that of FPR or FPRH surprisingly resulted in chimeras that were apparently retained in the endoplasmic reticulum. In contrast, when the NH2-terminal domain of FPR was replaced by the corresponding region from C5aR or FPRH normal expression to the plasma membrane and high affinity binding of N-formylated peptides were observed. Thus, the NH2-terminal region of C5aR, in contradistinction to that of FPR, seems to be required either for the translocation of C5aR through the ER membrane or for correct folding and sorting of C5aR to the plasma membrane. Replacement of the first 8 residues of C5aR by the corresponding region of FPR did not alter the cellular transport and the C5a binding capacity, whereas the exchange of the first 13 residues resulted in a chimera that was readily transported to the plasma membrane but showed no capability to bind C5a. Mutations of Asp into Asn in the NH2-terminal segment of C5aR further indicated that negative charges are required to endow the receptor with a C5a binding capacity. The residues critical for binding are either involved directly by interacting with cationic residues of C5a, or indirectly by influencing the overall structure of the ligand-binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.

Authors:  T M Woodruff; A J Strachan; S D Sanderson; P N Monk; A K Wong; D P Fairlie; S M Taylor
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

2.  Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.

Authors:  Y Shibuya; M Shiokawa; H Nishiura; T Nishimura; N Nishino; H Okabe; K Takagi; T Yamamoto
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.

Authors:  Anne-Marie Scola; Adrian Higginbottom; Lynda J Partridge; Robert C Reid; Trent Woodruff; Stephen M Taylor; David P Fairlie; Peter N Monk
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

4.  Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.

Authors:  T Dragic; A Trkola; S W Lin; K A Nagashima; F Kajumo; L Zhao; W C Olson; L Wu; C R Mackay; G P Allaway; T P Sakmar; J P Moore; P J Maddon
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.

Authors:  Soumendra Rana; Thomas J Baranski
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 6.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

7.  Complement component 5a receptor oligomerization and homologous receptor down-regulation.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  J Biol Chem       Date:  2008-09-04       Impact factor: 5.157

8.  Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase.

Authors:  Hiroshi Nishiura; Hideo Nonaka; Ivette S Revollo; Umeko Semba; Ying Li; Yoshihiko Ota; Atsushi Irie; Kumiko Harada; John H Kehrl; Tetsuro Yamamoto
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

Review 9.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

10.  Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.

Authors:  Andrew J Wright; Adrian Higginbottom; Didier Philippe; Abhishek Upadhyay; Stefan Bagby; Robert C Read; Peter N Monk; Lynda J Partridge
Journal:  Mol Immunol       Date:  2007-01-26       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.